ID

12215

Beschreibung

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02487017

Link

https://clinicaltrials.gov/show/NCT02487017

Stichworte

  1. 18.10.15 18.10.15 -
Hochgeladen am

18. Oktober 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatocellular Carcinoma NCT02487017

Eligibility Hepatocellular Carcinoma NCT02487017

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
18-80 years old;
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
histologically confirmed with hepatocellular carcinoma at stage i-ii;
Beschreibung

hepatocellular carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2239176
patients who can accept transcatheter arterial chemoembolization ;
Beschreibung

Transarterial Chemoembolization

Datentyp

boolean

Alias
UMLS CUI [1]
C3539919
patients who have a life expectancy of at least 3 months;
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
patients who have a child-pugh:a/b; .eastern cooperative oncology group (ecog) performance status was 0-2.
Beschreibung

ecog performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
white blood cell <3 x 10^9/l,platelet count <75 x 10^9/l;bun and cr more than normal limits on 3.0 times ;
Beschreibung

Blood Platelets; white blood cell

Datentyp

boolean

Alias
UMLS CUI [1]
C0005821
UMLS CUI [2]
C0023516
known or suspected allergy to the investigational agent or any agent given in association with this trial;
Beschreibung

allergy

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
pregnant or lactating patients;
Beschreibung

pregnant; lactating

Datentyp

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C2828358
known history of human immunodeficiency virus (hiv), hepatitis c virus (hcv) or treponemapallidun (tp) infection;
Beschreibung

human immunodeficiency virus (hiv) infection; hepatitis c virus (hcv)

Datentyp

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0220847
patients who are suffering from serious autoimmune disease;
Beschreibung

autoimmune disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0004364
patients who had used long time or are using immunosuppressant;
Beschreibung

immunosuppressant

Datentyp

boolean

Alias
UMLS CUI [1]
C0021081
patients who had active infection;
Beschreibung

infection; active

Datentyp

boolean

Alias
UMLS CUI [1]
C3714514
UMLS CUI [2]
C0205177
prior use of any anti-cancer treatment in 30 days;
Beschreibung

cancer treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0920425
now or recently will join another experimental clinical study ;
Beschreibung

clinical study

Datentyp

boolean

Alias
UMLS CUI [1]
C0008972
history of organ allograft;
Beschreibung

organ; allograft

Datentyp

boolean

Alias
UMLS CUI [1]
C0178784
UMLS CUI [2]
C0040739
other situations that the researchers considered unsuitable for this study
Beschreibung

Clinical Research; Disruption

Datentyp

boolean

Alias
UMLS CUI [1]
C0008972
UMLS CUI [2]
C0332453

Ähnliche Modelle

Eligibility Hepatocellular Carcinoma NCT02487017

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
18-80 years old;
boolean
C0001779 (UMLS CUI [1])
hepatocellular carcinoma
Item
histologically confirmed with hepatocellular carcinoma at stage i-ii;
boolean
C2239176 (UMLS CUI [1])
Transarterial Chemoembolization
Item
patients who can accept transcatheter arterial chemoembolization ;
boolean
C3539919 (UMLS CUI [1])
life expectancy
Item
patients who have a life expectancy of at least 3 months;
boolean
C0023671 (UMLS CUI [1])
ecog performance status
Item
patients who have a child-pugh:a/b; .eastern cooperative oncology group (ecog) performance status was 0-2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Blood Platelets; white blood cell
Item
white blood cell <3 x 10^9/l,platelet count <75 x 10^9/l;bun and cr more than normal limits on 3.0 times ;
boolean
C0005821 (UMLS CUI [1])
C0023516 (UMLS CUI [2])
allergy
Item
known or suspected allergy to the investigational agent or any agent given in association with this trial;
boolean
C0020517 (UMLS CUI [1])
pregnant; lactating
Item
pregnant or lactating patients;
boolean
C0549206 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
human immunodeficiency virus (hiv) infection; hepatitis c virus (hcv)
Item
known history of human immunodeficiency virus (hiv), hepatitis c virus (hcv) or treponemapallidun (tp) infection;
boolean
C0019693 (UMLS CUI [1])
C0220847 (UMLS CUI [2])
autoimmune disease
Item
patients who are suffering from serious autoimmune disease;
boolean
C0004364 (UMLS CUI [1])
immunosuppressant
Item
patients who had used long time or are using immunosuppressant;
boolean
C0021081 (UMLS CUI [1])
infection; active
Item
patients who had active infection;
boolean
C3714514 (UMLS CUI [1])
C0205177 (UMLS CUI [2])
cancer treatment
Item
prior use of any anti-cancer treatment in 30 days;
boolean
C0920425 (UMLS CUI [1])
clinical study
Item
now or recently will join another experimental clinical study ;
boolean
C0008972 (UMLS CUI [1])
organ; allograft
Item
history of organ allograft;
boolean
C0178784 (UMLS CUI [1])
C0040739 (UMLS CUI [2])
Clinical Research; Disruption
Item
other situations that the researchers considered unsuitable for this study
boolean
C0008972 (UMLS CUI [1])
C0332453 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video